ResearcherUniversidad de GranadaActive in the last 2 years

Pablo Hernández-Camarero

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0127-0283; OpenAlex author ID A5062013332. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

Impact of pancreatic proenzymes on pancreatic ductal adenocarcinoma associated fibroblasts. Co-author DOI 10.1038/s41598-025-24863-2 ↗
Pancreatic (pro)enzymes treatment suppresses BXPC-3 pancreatic Cancer Stem Cell subpopulation and impairs tumour engrafting. Co-author DOI 10.1038/s41598-019-47837-7 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Macarena Perán · 2 shared papers, 2019–2025 · strength 0.37
- Paper Impact of pancreatic proenzymes on pancreatic ductal adenocarcinoma associated fibroblasts. DOI 10.1038/s41598-025-24863-2 ↗
- Paper Pancreatic (pro)enzymes treatment suppresses BXPC-3 pancreatic Cancer Stem Cell subpopulation and impairs tumour engraf… DOI 10.1038/s41598-019-47837-7 ↗
Juan Antonio Marchal Corrales · 2 shared papers, 2019–2025 · strength 0.37
- Paper Impact of pancreatic proenzymes on pancreatic ductal adenocarcinoma associated fibroblasts. DOI 10.1038/s41598-025-24863-2 ↗
- Paper Pancreatic (pro)enzymes treatment suppresses BXPC-3 pancreatic Cancer Stem Cell subpopulation and impairs tumour engraf… DOI 10.1038/s41598-019-47837-7 ↗
Belén Toledo · 1 shared paper, 2025 · strength 0.27
- Paper Impact of pancreatic proenzymes on pancreatic ductal adenocarcinoma associated fibroblasts. DOI 10.1038/s41598-025-24863-2 ↗
Elisa Giovannetti · 1 shared paper, 2025 · strength 0.27
- Paper Impact of pancreatic proenzymes on pancreatic ductal adenocarcinoma associated fibroblasts. DOI 10.1038/s41598-025-24863-2 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.